The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis
Jinze Li, Lei Peng, Dehong Cao, Haocheng Gou, Yunxiang Li, Qiang Wei
Abstract
OBJECTIVE: We performed this meta-analysis to assess the association between metabolic syndrome (MetS) and benign prostatic hyperplasia (BPH). METHOD: We conducted extensive searches on the PubMed, Science and Cochrane Library to identify all articles. Outcomes including annual prostate growth rate, prostate volume (PV), International Prostate Symptom Score (IPSS), IPSS sub-scores (voiding and storage), prostate- specific antigen (PSA), maximum urine flow rate (Qmax), post-void residual urine volume (PVR) and quality of life (QoL) were assessed. RESULTS: = .70). CONCLUSIONS: The study suggested that MetS may be one of the risk factors for the clinical progress of BPH. However, further study is warranted to support these results.